Initial Results from a Biomarker-Directed Phase 2 Trial of SY-1425, a Potent and Selective RARα Agonist, in Combination with Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia

Stein, Eytan M. ; De Botton, Stephane ; Cluzeau, Thomas ; Pigneux, Arnaud ; Liesveld, Jane L. ; Cook, Rachel J. ; Rousselot, Philippe ; Rizzieri, David A ; Braun, Thorsten ; Bixby, Dale L. ; Roboz, Gail J. ; Lebon, Delphine ; Heiblig, Mael ; Kelly, Michael J. ; Volkert, Angela ; Zhou, Li ; Kang-Fortner, Qing ; Roth, David A. ; Peterlin, Pierre

Blood, 2020-11, Vol.136 (Supplement 1), p.6-7 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível